Size of burden of schizophrenia and psychotic disorders
- PMID: 15925493
- DOI: 10.1016/j.euroneuro.2005.04.009
Size of burden of schizophrenia and psychotic disorders
Abstract
Schizophrenia is a severe mental disorder characterised by fundamental disturbances in thinking, perception and emotions. More than 100 years of research have not been able to fully resolve the puzzle that schizophrenia represents. Even if schizophrenia is not a very frequent disease, it is among the most burdensome and costly illnesses worldwide. It usually starts in young adulthood. Life expectancy is reduced by approximately 10 years, mostly as a consequence of suicide. Even if the course of the illness today is considered more favourable than it was originally described, it is still only a minority of those affected, who fully recover. The cumulative lifetime risk for men and women is similar, although it is higher for men in the age group younger than 40 years. According to the Global Burden of Disease Study, schizophrenia causes a high degree of disability, which accounts for 1.1% of the total DALYs (disability-adjusted life years) and 2.8% of YLDs (years lived with disability). In the World Health Report [The WHO World Health Report: new understanding, new hope, 2001. Geneva], schizophrenia is listed as the 8th leading cause of DALYs worldwide in the age group 15-44 years. In addition to the direct burden, there is considerable burden on the relatives who care for the sufferers. The treatment goals for the moment are to identify the illness as early as possible, treat the symptoms, provide skills to patients and their families, maintain the improvement over a period of time, prevent relapses and reintegrate the ill persons into the community so that they can lead as normal a life as possible.
Similar articles
-
[Study of the impact of an assertive community program on the families of patients with severe mental disorders].Encephale. 2012 Jun;38(3):201-10. doi: 10.1016/j.encep.2011.11.006. Epub 2012 Jan 5. Encephale. 2012. PMID: 22726408 French.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
-
[What support of young presenting a first psychotic episode, when schooling is being challenged?].Encephale. 2017 Dec;43(6):570-576. doi: 10.1016/j.encep.2017.10.001. Epub 2017 Nov 8. Encephale. 2017. PMID: 29128195 Review. French.
-
Assessing cost-effectiveness in mental health: family interventions for schizophrenia and related conditions.Aust N Z J Psychiatry. 2004 Jul;38(7):511-9. doi: 10.1080/j.1440-1614.2004.01404.x. Aust N Z J Psychiatry. 2004. PMID: 15255823
-
The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.PLoS One. 2015 Feb 6;10(2):e0116820. doi: 10.1371/journal.pone.0116820. eCollection 2015. PLoS One. 2015. PMID: 25658103 Free PMC article.
Cited by
-
Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies.Schizophr Bull Open. 2022 Oct 21;3(1):sgac067. doi: 10.1093/schizbullopen/sgac067. eCollection 2022 Jan. Schizophr Bull Open. 2022. PMID: 36387971 Free PMC article.
-
A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocol.BMC Psychiatry. 2015 Feb 14;15:22. doi: 10.1186/s12888-015-0404-2. BMC Psychiatry. 2015. PMID: 25881022 Free PMC article. Clinical Trial.
-
Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.Neuropsychiatr Dis Treat. 2022 Aug 11;18:1705-1713. doi: 10.2147/NDT.S374577. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 35979228 Free PMC article.
-
Overweight or Obesity among Chinese Han People with Schizophrenia: Demographic, Clinical and Cognitive Correlations.Brain Sci. 2023 Aug 26;13(9):1245. doi: 10.3390/brainsci13091245. Brain Sci. 2023. PMID: 37759846 Free PMC article.
-
A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda.BMJ Open. 2019 Jul 16;9(7):e028029. doi: 10.1136/bmjopen-2018-028029. BMJ Open. 2019. PMID: 31315866 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical